Brain-Shield drug added to Clot-Buster in major stroke recovery trial
NCT ID NCT07369999
Summary
This study is testing if adding a brain-protecting drug (butylphthalide) to a standard clot-dissolving medicine (tenecteplase) helps people recover better after a mild but disabling stroke. Over 1,000 participants who have a stroke with mild symptoms but still have trouble with speech, vision, or movement will be enrolled. The main goal is to see if more people return to near-normal function 90 days after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD DISABLING ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.